BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Clinical News

Octreotide acetate: Phase II completed enrollment

WIR Staff
August 9, 2004 7:00 AM UTC

Valera completed enrollment of 12 patients in a Phase II trial. ...

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Cookie Policy
California Privacy Rights
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS